PT  - JOURNAL ARTICLE
AU  - Mohamed Hassanein
AU  - Yeshwanter Radhakrishnan
AU  - John Sedor
AU  - Tushar Vachharajani
AU  - Vidula T. Vachharajani
AU  - Joshua Augustine
AU  - Sevag Demirjian
AU  - George Thomas
TI  - COVID-19 and the kidney
AID  - 10.3949/ccjm.87a.20072
DP  - 2020 Oct 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 619--631
VI  - 87
IP  - 10
4099  - http://www.ccjm.org/content/87/10/619.short
4100  - http://www.ccjm.org/content/87/10/619.full
SO  - Cleve Clin J Med2020 Oct 01; 87
AB  - COVID-19 is primarily considered a respiratory illness, but the kidney may be one of the targets of SARS-CoV-2 infection, since the virus enters cells through the angiotensin-converting enzyme 2 receptor, which is found in abundance in the kidney. Information on kidney involvement in COVID-19 is limited but is evolving rapidly. This article discusses the pathogenesis of acute kidney injury (AKI) in COVID-19, its optimal management, and the impact of COVID-19 on patients with chronic kidney disease, patients with end-stage kidney disease on dialysis, and kidney transplant recipients.